As a leader in health and nutrition, something is always happening at Bayer and in the countless communities we serve. Take a look below—and check back often—to explore some of our most exciting stories as they emerge.
Your Selection
Clear All
Latest News
AskBio presents 18-month Phase Ib trial results of AB-1005 gene therapy for patients with Parkinson’s disease
Sue Ann Pentecost Headshot
Bayer Appoints Sue Ann Pentecost as Vice President, Head of U.S. Pharmaceutical Communications
Positive topline results from Phase III long-term study OASIS 3 support submissions for marketing authorization for Bayer’s elinzanetant
Bayer employees at a team event
Bayer Honored as Newsweek’s America’s Greatest Workplaces 2024 for Diversity
Bayer and Aignostics to collaborate on next generation precision oncology
BlueRock Therapeutics phase I clinical trial for Parkinson’s disease continues to show positive trends at 18 months
Bayer Wins Third Consecutive Trial Victory
Bayer Carbon Program Expands Eligibility, Creates New Potential Revenue Streams for Thousands of US Farmers

More Bayer U.S. news